Afya (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon Sells 2,320 Shares

Afya Limited (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon sold 2,320 shares of the business’s stock in a transaction dated Tuesday, March 31st. The shares were sold at an average price of $14.92, for a total value of $34,614.40. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Virgilio Deloy Capobian Gibbon also recently made the following trade(s):

• On Wednesday, April 1st, Virgilio Deloy Capobian Gibbon sold 19,500 shares of Afya stock. The stock was sold at an average price of $14.98, for a total value of $292,110.00.
• On Thursday, March 26th, Virgilio Deloy Capobian Gibbon sold 800 shares of Afya stock. The shares were sold at an average price of $15.21, for a total value of $12,168.00.
• On Wednesday, March 25th, Virgilio Deloy Capobian Gibbon sold 3,900 shares of Afya stock. The shares were sold at an average price of $15.18, for a total value of $59,202.00.

Afya Trading Down 0.1%

Afya stock opened at $14.96 on Friday. Afya Limited has a 12-month low of $13.00 and a 12-month high of $19.90. The firm has a market capitalization of $1.40 billion, a price-to-earnings ratio of 10.25, a P/E/G ratio of 0.67 and a beta of 0.48. The firm has a 50 day moving average of $14.46 and a 200 day moving average of $14.73. The company has a current ratio of 2.20, a quick ratio of 0.98 and a debt-to-equity ratio of 0.21.

Afya (NASDAQ:AFYA) last posted its quarterly earnings results on Wednesday, March 11th. The company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.05. The business had revenue of $147.08 million during the quarter, compared to analyst estimates of $174.74 million. Afya had a net margin of 20.31% and a return on equity of 18.77%. As a group, research analysts predict that Afya Limited will post 1.52 earnings per share for the current year.

Afya Announces Dividend

The firm also recently declared an annual dividend, which will be paid on Monday, April 6th. Shareholders of record on Wednesday, March 25th will be paid a $0.656 dividend. This represents a yield of 433.0%. The ex-dividend date is Wednesday, March 25th. Afya’s dividend payout ratio is presently 45.21%.

Institutional Trading of Afya

Several hedge funds have recently modified their holdings of the company. Daiwa Securities Group Inc. bought a new position in shares of Afya during the 4th quarter valued at approximately $43,000. Militia Capital Partners LP bought a new stake in Afya in the second quarter worth $71,000. Quantbot Technologies LP purchased a new stake in Afya during the second quarter valued at $117,000. Van ECK Associates Corp lifted its position in Afya by 15.7% during the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock valued at $159,000 after purchasing an additional 1,377 shares during the last quarter. Finally, State of Wyoming purchased a new position in shares of Afya in the 2nd quarter worth $164,000. 88.02% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Wall Street Zen upgraded Afya from a “buy” rating to a “strong-buy” rating in a research report on Saturday, March 14th. UBS Group reissued a “neutral” rating and set a $16.00 target price (down from $18.00) on shares of Afya in a research note on Friday, January 16th. Bank of America cut Afya from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $22.00 to $17.00 in a report on Tuesday, February 24th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $22.00 price target (down from $24.50) on shares of Afya in a research note on Wednesday, January 7th. Finally, Sanford C. Bernstein raised shares of Afya to a “market perform” rating in a report on Friday, January 16th. One equities research analyst has rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Afya has an average rating of “Hold” and a consensus target price of $17.30.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.